Diagnosis and fine localization of deletion region in Wolf-Hirschhorn syndrome patients.

BACKGROUND Wolf-Hirschhorn syndrome (WHS) results from the partial deletion of 4p. This study aimed to identify and fine map the chromosome deletion regions of Chinese children with Wolf-Hirschhorn syndrome among the developmental delay/mental retardation (DD/MR) patients. METHODS We analyzed the relationship of phenotype and genotype. Inclusion criteria were: moderate to severe DD/MR, no definite perinatal brain injury, and no trauma, toxication, hypoxia, infection of central nervous system; routine karyotyping was normal, no evidence of typical inherited metabolic disorder or specific neurodegenerative disorders from cranial neuro-imaging and blood/urinary metabolic diseases screening; no mutation of FMR1 in male patients, no typical clinical manifestation of Rett syndrome in female patients. Multiplex ligation-dependent probe amplification (MLPA) and Affymetrix genome-wide human SNP array 6.0 assays were applied to accurately define the exact size of subtelomeric aberration region of four WHS patients. RESULTS All four WHS patients presented with severe DD, hypotonia and microcephaly, failure to thrive, 3/4 patients with typical facial features and seizures, 2/4 patients with congenital heart defects and cleft lip/palate, 1/4 patients with other malformations. The length of the deletions ranged from 3.3 Mb to 9.8 Mb. Two of four patients had "classic" WHS, 1/4 patients had "mild"-to-"classic" WHS, and 1/4 patients had "mild" WHS. CONCLUSIONS WHS patients in China appear to be consistent with those previously reported. The prevalence of signs and symptoms, distribution of cases between "mild" and "classic" WHS, and the correlation between length of deletion and severity of disease of these patients were all similar to those of the patients from other populations.

[1]  A. Battaglia,et al.  Update on the clinical features and natural history of Wolf–Hirschhorn (4p‐) syndrome: Experience with 87 patients and recommendations for routine health supervision , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[2]  A. Bergemann,et al.  Mouse models of Wolf–Hirschhorn syndrome , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[3]  G. Neri,et al.  On the nosology and pathogenesis of Wolf–Hirschhorn syndrome: Genotype–phenotype correlation analysis of 80 patients and literature review , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[4]  A. Battaglia,et al.  Comprehensive analysis of Wolf–Hirschhorn syndrome using array CGH indicates a high prevalence of translocations , 2008, European Journal of Human Genetics.

[5]  K. Devriendt,et al.  Genotype–phenotype correlation in 21 patients with Wolf–Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH) , 2007, Journal of Medical Genetics.

[6]  M. Poot,et al.  Unmasking of a hemizygous WFS1 gene mutation by a chromosome 4p deletion of 8.3 Mb in a patient with Wolf–Hirschhorn syndrome , 2007, European Journal of Human Genetics.

[7]  A. Battaglia,et al.  Seizure and EEG patterns in Wolf-Hirschhorn (4p-) syndrome , 2005, Brain and Development.

[8]  K. Hirschhorn,et al.  The etiology of Wolf-Hirschhorn syndrome. , 2005, Trends in genetics : TIG.

[9]  A. Ebbin,et al.  Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)] , 2004, Human Genetics.

[10]  G. Neri,et al.  Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. , 2003, American journal of human genetics.

[11]  A. Battaglia,et al.  Wolf-Hirschhorn (4p-) syndrome. , 2005, Advances in pediatrics.

[12]  H. Dörr,et al.  First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype-phenotype correlation. , 2001, American journal of medical genetics.

[13]  A. Battaglia,et al.  Wolf-Hirschhorn syndrome (WHS): a history in pictures. , 2000, Clinical dysmorphology.

[14]  M. Altherr,et al.  Comparative analysis of a novel gene from the Wolf-Hirschhorn/Pitt-Rogers-Danks syndrome critical region. , 1999, Genomics.

[15]  A. Battaglia,et al.  Natural History of Wolf-Hirschhorn Syndrome: Experience With 15 Cases , 1999, Pediatrics.

[16]  A. Moorman,et al.  WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. , 1998, Human molecular genetics.

[17]  E. Zackai,et al.  A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. , 1997, Human molecular genetics.

[18]  D. Ledbetter,et al.  Summary of the 1993 ASHG ancillary meeting "recent research on chromosome 4p syndromes and genes". , 1995, American journal of medical genetics.